IQVIA Holdings Inc
(FRA:QTS)
€
199.5
3.45 (1.76%)
Market Cap: 36.32 Bil
Enterprise Value: 47.64 Bil
PE Ratio: 29.08
PB Ratio: 6.11
GF Score: 90/100 - Q1 2024 IQVIA Holdings Inc Earnings Call TranscriptMay 02, 2024€206.5 (-4.66%)Earnings
- IQVIA Holdings Inc at Citigroup Inc Unplugged Medtech and Life Sciences Access Day TranscriptFeb 29, 2024
- Q4 2023 IQVIA Holdings Inc Earnings Call TranscriptFeb 14, 2024€226 (+13.00%)Earnings
- IQVIA Holdings Inc at Evercore ISI HealthCONx Conference TranscriptNov 29, 2023
- Q3 2023 IQVIA Holdings Inc Earnings Call TranscriptNov 01, 2023€168.8 (+2.18%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2023
- IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 IQVIA Holdings Inc Earnings Call TranscriptAug 01, 2023€199 (-1.73%)Earnings
- IQVIA Holdings Inc. - Special Call TranscriptMay 24, 2023
- Q1 2023 IQVIA Holdings Inc Earnings Call TranscriptApr 27, 2023€164.6 (-3.18%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 IQVIA Holdings Inc Earnings Call TranscriptFeb 10, 2023€208.4 (-2.71%)Earnings
- IQVIA Holdings Inc Corporate Call TranscriptJan 18, 2023
- IQVIA Holdings Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 IQVIA Holdings Inc Earnings Call TranscriptOct 26, 2022€200.1 (+1.47%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 14, 2022
- IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 IQVIA Holdings Inc Earnings Call TranscriptJul 21, 2022€220.7 (+1.92%)Earnings
- IQVIA Holdings Inc at Jefferies Healthcare Conference TranscriptJun 10, 2022
- IQVIA Holdings Inc. - Special Call TranscriptMay 04, 2022
- Q1 2022 IQVIA Holdings Inc Earnings Call TranscriptApr 27, 2022€198.92 (+2.72%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- IQVIA Holdings Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 24, 2022
- Q4 2021 IQVIA Holdings Inc Earnings Call TranscriptFeb 15, 2022€200.4 (-5.20%)Earnings
- IQVIA Holdings Inc Analyst and Investor Conference (Virtual) TranscriptNov 16, 2021
- Q3 2021 IQVIA Holdings Inc Earnings Call TranscriptOct 21, 2021€217.4 (+0.69%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 IQVIA Holdings Inc Earnings Call TranscriptJul 27, 2021€203 (-2.54%)Earnings
- IQVIA Holdings Inc at William Blair Growth Stock Conference (Virtual) TranscriptJun 02, 2021
- Q1 2021 IQVIA Holdings Inc Earnings Call TranscriptApr 22, 2021€185.95 (+1.95%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 IQVIA Holdings Inc Earnings Call TranscriptFeb 10, 2021€156 (+1.96%)Earnings
- Q3 2020 IQVIA Holdings Inc Earnings Call TranscriptOct 20, 2020€146 (+5.04%)Earnings
- Q2 2020 IQVIA Holdings Inc Earnings Call TranscriptJul 22, 2020€140 (+2.19%)Earnings
- Q1 2020 IQVIA Holdings Inc Earnings Call TranscriptApr 28, 2020€125 (+4.17%)Earnings
- Q4 2019 IQVIA Holdings Inc Earnings Call TranscriptFeb 12, 2020€152 (+2.70%)Earnings
- Q3 2019 IQVIA Holdings Inc Earnings Call TranscriptOct 30, 2019€129 (-4.44%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 04, 2019
- Q2 2019 IQVIA Holdings Inc Earnings Call TranscriptJul 24, 2019€142.94 (+1.94%)Earnings
- IQVIA Holdings Inc Analyst and Investor Conference TranscriptJun 18, 2019
- IQVIA Holdings Inc at William Blair Growth Stock Conference TranscriptJun 05, 2019
- Q1 2019 IQVIA Holdings Inc Earnings Call TranscriptMay 01, 2019€123.58Earnings
- IQVIA Holdings Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mediterranean TranscriptApr 23, 2019
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 IQVIA Holdings Inc Earnings Call TranscriptFeb 14, 2019€124.71 (+8.04%)Earnings
IQVIA Holdings Inc at Credit Suisse Healthcare Conference Transcript
Nov 08, 2022 / 05:10PM GMT
Release Date Price:
€204.75
(-0.10%)
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
All right. With that, we'll kick things off. Thank you, everybody, for joining us. Next session is IQVIA. We're happy to have with us Ron Bruehlman, CFO. I'm Dan Leonard. I cover life science tools and services for Credit Suisse. And we'll kick things straight off. Ron, welcome.
Ronald E. Bruehlman
IQVIA Holdings Inc. - Executive VP & CFO
Thank you.
Questions & Answers
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
So you just closed up your Q3 -- reported Q3 earnings. Figured a good way to start off would be to remind us of the key highlights and takeaways from the Q3 report.
Ronald E. Bruehlman
IQVIA Holdings Inc. - Executive VP & CFO
Sure. Well, look, I think the #1 highlight, Dan, is that the market remains very strong for us. I know there's been concern, particularly about the emerging
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)